Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients
Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients
Active, not recruiting · NCT05234190 · Registry updated 2026-07-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients | Digestive System Diseases, Hepatic Insufficiency, liver disorder, liver failure | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-02 | NCT05234190 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Quell Therapeutics Limited | 3 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cambridge University Hospitals NHS Foundation Trust | Cambridge | United Kingdom | 34 |
| G. Gergorio Maranon | Madrid | Spain | 1 |
| H. Clinic Barcelona | Barcelona | Spain | 1 |
| H. Saint Luc | Brussels | Belgium | 1 |
| Hopital Erasme | Brussels | Belgium | 2 |
| Hospital Reina Sofia | Córdoba | Spain | 2 |
| King's College Hospital NHS Foundation Trust | London | United Kingdom | 31 |
| Queen Elizabeth Hospital | Birmingham | United Kingdom | 23 |
| Royal Free London NHS Foundation Trust | London | United Kingdom | 17 |
| UZ Leuven | Leuven | Belgium | 236 |